Cypherpunk Technologies Inc.
CYPH
Rank in Stocks
#15590
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Share Price
$2.36
Last synced: 2026-11-09
Market Cap
$254.32M
Change (1 day)
-18.06%
Change (1 year)
15.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cypherpunk Technologies Inc. (CYPH)
Category
Healthcare
Operating Margin for Cypherpunk Technologies Inc. (CYPH)
Operating Margin as of November 2026 TTM: 0.00%
According to Cypherpunk Technologies Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Cypherpunk Technologies Inc. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -2,761.73% | 7,956.39% |
| 2020 | -34.28% | -4.54% |
| 2019 | -35.91% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cypherpunk Technologies Inc.'s operating margin
What was Cypherpunk Technologies Inc.'s operating margin in 2025?
In 2025, Cypherpunk Technologies Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Cypherpunk Technologies Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cypherpunk Technologies Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2021 (-2,761.73%).
How does Cypherpunk Technologies Inc.'s operating margin compare with similar companies?
Cypherpunk Technologies Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.